CENTOGENE Signs Strategic Transaction With Private Equity Group Charme Capital Partners
November 13, 2024
Medical Diagnostics & Screening
-
-
Prenetics Announces Tencent’s US$30 Million Investment in Insighta, Strengthening Strategic Partnership for AI-Driven Early Cancer Detection
October 15, 2024
-
23andMe Announces 1-for-20 Reverse Stock Split
October 11, 2024
-
Angle PLC Announces 100th Publication Supporting Parsortix System Use
September 26, 2024
-
Prenetics Announces Acquisition of Europa Sports Partners in Strategic Expansion to Consumer Health and Wellness Industry
August 19, 2024
-
Personalis and Tempus Announce Expanded Collaboration
August 16, 2024
-
Genetic Technologies Announces Global Launch of geneType(TM) on Wholly Owned EasyDNA platform
August 15, 2024
-
Neuronetics and Greenbrook TMS Announce Definitive Agreement to Merge
August 12, 2024
-
Intelligent Bio Solutions Partners with CenExel to Conduct Clinical Study as Part of FDA 510(k) Pathway
August 1, 2024
-
Prenetics, NASDAQ Health Sciences Company, Partners with David BeckhamÂ
July 11, 2024
-
Mainz Biomed Announces Submission for FDA Breakthrough Device Designation for its Next Generation CRC Screening Test
July 9, 2024
-
Mainz Biomed Provides Half Year 2024 Corporate Update
July 2, 2024
-
23andMe Launches New Genetic Report on Bipolar Disorder
June 5, 2024
-
Mainz Biomed Presented Industry Leading Results of its Pooled Study at ASCO 2024
June 3, 2024
-
T2 Biosystems Regains Compliance with Nasdaq Continued Listing Requirements
May 22, 2024
-
Mainz Biomed Awarded Poster of Distinction at Digestive Disease Week, Positioning the Company for its Planned FDA Trial
May 20, 2024